ArticleOncology research2026

Elevated C-Reactive Protein as a Potential Biomarker for Neurological Adverse Events in Immune Checkpoint Inhibitor Therapy: A Prospective Cohort Study.

Laura Duzzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.